Sustained remission of multicentric Castleman disease in children treated with tocilizumab, an anti-interleukin-6 receptor antibody.
Galeotti, Caroline
Sustained remission of multicentric Castleman disease in children treated with tocilizumab, an anti-interleukin-6 receptor antibody. [electronic resource] - Molecular cancer therapeutics Aug 2012 - 1623-6 p. digital
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
1538-8514
10.1158/1535-7163.MCT-11-0972 doi
Antibodies, Monoclonal, Humanized--administration & dosage
Antineoplastic Agents--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Castleman Disease--diagnosis
Child
Female
Humans
Male
Receptors, Interleukin-6--antagonists & inhibitors
Remission Induction
Treatment Outcome
Sustained remission of multicentric Castleman disease in children treated with tocilizumab, an anti-interleukin-6 receptor antibody. [electronic resource] - Molecular cancer therapeutics Aug 2012 - 1623-6 p. digital
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
1538-8514
10.1158/1535-7163.MCT-11-0972 doi
Antibodies, Monoclonal, Humanized--administration & dosage
Antineoplastic Agents--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Castleman Disease--diagnosis
Child
Female
Humans
Male
Receptors, Interleukin-6--antagonists & inhibitors
Remission Induction
Treatment Outcome